510(k) Report

FDA applicant

Biomerics

Salt Lake City, UT2 decisions2012–20200 recalls

FDA records 2 decisions for Biomerics (Salt Lake City, UT) from 2012 to 2020: 2 510(k) clearances. All are in product code GXI (Probe, Radiofrequency Lesion). Its devices cite 2 predicates, 1 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Biomerics’s devices, and how often a recall has named them.

FDA decisions per year

1in 2020

2012: 12020: 1
2012high 1 (2012) · low 0 (2013)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2012.

FIG. 1 — Biomerics by year, 2012–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Biomerics’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • GXIProbe, Radiofrequency Lesion2decisions

Whose devices does it build on?

Its devices cite 2 predicates; 1 are its own earlier devices. The firms it cites most:

Who builds on its devices?

Later devices cite its devices 2 times; 1 of those are its own. The firms that cite it most:

Which of its devices are cited most?

Its devices that later submissions most often claim equivalence to.

  • K121773Nimbus Electrosurgical Radiofrequency Multitined Expandable ElectrodeBiomerics · 20122cite it

What has FDA decided for it lately?

  • K190259Vesta RF CannulaBiomerics · 2020
  • K121773Nimbus Electrosurgical Radiofrequency Multitined Expandable ElectrodeBiomerics · 2012

All 2 as Biomerics →

Other applicant names beginning “Biomerics”

FDA records each applicant name separately; these may or may not be the same firm.

Biomerics Nle 2